Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1994 Sep 13;91(19):9160–9164. doi: 10.1073/pnas.91.19.9160

Phosphatase inhibitors activate normal and defective CFTR chloride channels.

F Becq 1, T J Jensen 1, X B Chang 1, A Savoia 1, J M Rommens 1, L C Tsui 1, M Buchwald 1, J R Riordan 1, J W Hanrahan 1
PMCID: PMC44767  PMID: 7522329

Abstract

The cystic fibrosis transmembrane conductance regulator (CFTR) chloride channel is regulated by phosphorylation and dephosphorylation at multiple sites. Although activation by protein kinases has been studied in some detail, the dephosphorylation step has received little attention. This report examines the mechanisms responsible for the dephosphorylation and spontaneous deactivation ("rundown") of CFTR chloride channels excised from transfected Chinese hamster ovary (CHO) and human airway epithelial cells. We report that the alkaline phosphatase inhibitors bromotetramisole, 3-isobutyl-1-methylxanthine, theophylline, and vanadate slow the rundown of CFTR channel activity in excised membrane patches and reduce dephosphorylation of CFTR protein in isolated membranes. It was also found that in unstimulated cells, CFTR channels can be activated by exposure to phosphatase inhibitors alone. Most importantly, exposure of mammalian cells to phosphatase inhibitors alone activates CFTR channels that have disease-causing mutations, provided the mutant channels are present in the plasma membrane (R117H, G551D, and delta F508 after cooling). These results suggest that CFTR dephosphorylation is dynamic and that membrane-associated phosphatase activity may be a potential therapeutic target for the treatment of cystic fibrosis.

Full text

PDF
9160

Images in this article

9161Image
on p.9161
9163Image
on p.9163
9164Image
on p.9164

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson M. P., Berger H. A., Rich D. P., Gregory R. J., Smith A. E., Welsh M. J. Nucleoside triphosphates are required to open the CFTR chloride channel. Cell. 1991 Nov 15;67(4):775–784. doi: 10.1016/0092-8674(91)90072-7. [DOI] [PubMed] [Google Scholar]
  2. Bear C. E., Li C. H., Kartner N., Bridges R. J., Jensen T. J., Ramjeesingh M., Riordan J. R. Purification and functional reconstitution of the cystic fibrosis transmembrane conductance regulator (CFTR). Cell. 1992 Feb 21;68(4):809–818. doi: 10.1016/0092-8674(92)90155-6. [DOI] [PubMed] [Google Scholar]
  3. Becq F., Fanjul M., Merten M., Figarella C., Hollande E., Gola M. Possible regulation of CFTR-chloride channels by membrane-bound phosphatases in pancreatic duct cells. FEBS Lett. 1993 Aug 2;327(3):337–342. doi: 10.1016/0014-5793(93)81016-s. [DOI] [PubMed] [Google Scholar]
  4. Becq F., Hollande E., Gola M. Phosphorylation-regulated low-conductance Cl- channels in a human pancreatic duct cell line. Pflugers Arch. 1993 Oct;425(1-2):1–8. doi: 10.1007/BF00374496. [DOI] [PubMed] [Google Scholar]
  5. Bell D. R., Gerlach J. H., Kartner N., Buick R. N., Ling V. Detection of P-glycoprotein in ovarian cancer: a molecular marker associated with multidrug resistance. J Clin Oncol. 1985 Mar;3(3):311–315. doi: 10.1200/JCO.1985.3.3.311. [DOI] [PubMed] [Google Scholar]
  6. Berger H. A., Travis S. M., Welsh M. J. Regulation of the cystic fibrosis transmembrane conductance regulator Cl- channel by specific protein kinases and protein phosphatases. J Biol Chem. 1993 Jan 25;268(3):2037–2047. [PubMed] [Google Scholar]
  7. Bialojan C., Takai A. Inhibitory effect of a marine-sponge toxin, okadaic acid, on protein phosphatases. Specificity and kinetics. Biochem J. 1988 Nov 15;256(1):283–290. doi: 10.1042/bj2560283. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Borgers M., Thoné F. The inhibition of alkaline phosphatase by L-p-bromotetramisole. Histochemistry. 1975 Aug 28;44(3):277–280. doi: 10.1007/BF00491496. [DOI] [PubMed] [Google Scholar]
  9. Champigny G., Verrier B., Gérard C., Mauchamp J., Lazdunski M. Small conductance chloride channels in the apical membrane of thyroid cells. FEBS Lett. 1990 Jan 1;259(2):263–268. doi: 10.1016/0014-5793(90)80024-d. [DOI] [PubMed] [Google Scholar]
  10. Chan J. R., Stinson R. A. Dephosphorylation of phosphoproteins of human liver plasma membranes by endogenous and purified liver alkaline phosphatases. J Biol Chem. 1986 Jun 15;261(17):7635–7639. [PubMed] [Google Scholar]
  11. Chang X. B., Tabcharani J. A., Hou Y. X., Jensen T. J., Kartner N., Alon N., Hanrahan J. W., Riordan J. R. Protein kinase A (PKA) still activates CFTR chloride channel after mutagenesis of all 10 PKA consensus phosphorylation sites. J Biol Chem. 1993 May 25;268(15):11304–11311. [PubMed] [Google Scholar]
  12. Cheng S. H., Rich D. P., Marshall J., Gregory R. J., Welsh M. J., Smith A. E. Phosphorylation of the R domain by cAMP-dependent protein kinase regulates the CFTR chloride channel. Cell. 1991 Sep 6;66(5):1027–1036. doi: 10.1016/0092-8674(91)90446-6. [DOI] [PubMed] [Google Scholar]
  13. Collins F. S. Cystic fibrosis: molecular biology and therapeutic implications. Science. 1992 May 8;256(5058):774–779. doi: 10.1126/science.1375392. [DOI] [PubMed] [Google Scholar]
  14. Croce M. A., Kramer G. L., Garbers D. L. Inhibition of alkaline phosphatase by substituted xanthines. Biochem Pharmacol. 1979 Apr 1;28(7):1227–1231. doi: 10.1016/0006-2952(79)90334-4. [DOI] [PubMed] [Google Scholar]
  15. Cutting G. R., Kasch L. M., Rosenstein B. J., Zielenski J., Tsui L. C., Antonarakis S. E., Kazazian H. H., Jr A cluster of cystic fibrosis mutations in the first nucleotide-binding fold of the cystic fibrosis conductance regulator protein. Nature. 1990 Jul 26;346(6282):366–369. doi: 10.1038/346366a0. [DOI] [PubMed] [Google Scholar]
  16. Denning G. M., Anderson M. P., Amara J. F., Marshall J., Smith A. E., Welsh M. J. Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive. Nature. 1992 Aug 27;358(6389):761–764. doi: 10.1038/358761a0. [DOI] [PubMed] [Google Scholar]
  17. Dils F. A placebo controlled, double-blind evaluation of levamisole in the reduction of the frequency, duration and severity of attacks in children suffering from recurrent upper respiratory tract infections. J Int Med Res. 1979;7(4):302–304. doi: 10.1177/030006057900700408. [DOI] [PubMed] [Google Scholar]
  18. Drumm M. L., Wilkinson D. J., Smit L. S., Worrell R. T., Strong T. V., Frizzell R. A., Dawson D. C., Collins F. S. Chloride conductance expressed by delta F508 and other mutant CFTRs in Xenopus oocytes. Science. 1991 Dec 20;254(5039):1797–1799. doi: 10.1126/science.1722350. [DOI] [PubMed] [Google Scholar]
  19. Eidelman O., Guay-Broder C., van Galen P. J., Jacobson K. A., Fox C., Turner R. J., Cabantchik Z. I., Pollard H. B. A1 adenosine-receptor antagonists activate chloride efflux from cystic fibrosis cells. Proc Natl Acad Sci U S A. 1992 Jun 15;89(12):5562–5566. doi: 10.1073/pnas.89.12.5562. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Farley J. R., Ivey J. L., Baylink D. J. Human skeletal alkaline phosphatase. Kinetic studies including pH dependence and inhibition by theophylline. J Biol Chem. 1980 May 25;255(10):4680–4686. [PubMed] [Google Scholar]
  21. Fredholm B. B., Hedqvist P., Vernet L. Effect of theophylline and other drugs on rabbit renal cyclic nucleotide phosphodiesterase, 5'-nucleotidase and adenosine deaminase. Biochem Pharmacol. 1978;27(24):2845–2850. doi: 10.1016/0006-2952(78)90199-5. [DOI] [PubMed] [Google Scholar]
  22. Gray M. A., Harris A., Coleman L., Greenwell J. R., Argent B. E. Two types of chloride channel on duct cells cultured from human fetal pancreas. Am J Physiol. 1989 Aug;257(2 Pt 1):C240–C251. doi: 10.1152/ajpcell.1989.257.2.C240. [DOI] [PubMed] [Google Scholar]
  23. Gregory R. J., Rich D. P., Cheng S. H., Souza D. W., Paul S., Manavalan P., Anderson M. P., Welsh M. J., Smith A. E. Maturation and function of cystic fibrosis transmembrane conductance regulator variants bearing mutations in putative nucleotide-binding domains 1 and 2. Mol Cell Biol. 1991 Aug;11(8):3886–3893. doi: 10.1128/mcb.11.8.3886. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Haws C., Krouse M. E., Xia Y., Gruenert D. C., Wine J. J. CFTR channels in immortalized human airway cells. Am J Physiol. 1992 Dec;263(6 Pt 1):L692–L707. doi: 10.1152/ajplung.1992.263.6.L692. [DOI] [PubMed] [Google Scholar]
  25. Hescheler J., Mieskes G., Rüegg J. C., Takai A., Trautwein W. Effects of a protein phosphatase inhibitor, okadaic acid, on membrane currents of isolated guinea-pig cardiac myocytes. Pflugers Arch. 1988 Aug;412(3):248–252. doi: 10.1007/BF00582504. [DOI] [PubMed] [Google Scholar]
  26. Kartner N., Augustinas O., Jensen T. J., Naismith A. L., Riordan J. R. Mislocalization of delta F508 CFTR in cystic fibrosis sweat gland. Nat Genet. 1992 Aug;1(5):321–327. doi: 10.1038/ng0892-321. [DOI] [PubMed] [Google Scholar]
  27. Kartner N., Hanrahan J. W., Jensen T. J., Naismith A. L., Sun S. Z., Ackerley C. A., Reyes E. F., Tsui L. C., Rommens J. M., Bear C. E. Expression of the cystic fibrosis gene in non-epithelial invertebrate cells produces a regulated anion conductance. Cell. 1991 Feb 22;64(4):681–691. doi: 10.1016/0092-8674(91)90498-n. [DOI] [PubMed] [Google Scholar]
  28. Kerem B., Rommens J. M., Buchanan J. A., Markiewicz D., Cox T. K., Chakravarti A., Buchwald M., Tsui L. C. Identification of the cystic fibrosis gene: genetic analysis. Science. 1989 Sep 8;245(4922):1073–1080. doi: 10.1126/science.2570460. [DOI] [PubMed] [Google Scholar]
  29. Kume H., Takai A., Tokuno H., Tomita T. Regulation of Ca2+-dependent K+-channel activity in tracheal myocytes by phosphorylation. Nature. 1989 Sep 14;341(6238):152–154. doi: 10.1038/341152a0. [DOI] [PubMed] [Google Scholar]
  30. Picciotto M. R., Cohn J. A., Bertuzzi G., Greengard P., Nairn A. C. Phosphorylation of the cystic fibrosis transmembrane conductance regulator. J Biol Chem. 1992 Jun 25;267(18):12742–12752. [PubMed] [Google Scholar]
  31. Quinton P. M., Reddy M. M. Control of CFTR chloride conductance by ATP levels through non-hydrolytic binding. Nature. 1992 Nov 5;360(6399):79–81. doi: 10.1038/360079a0. [DOI] [PubMed] [Google Scholar]
  32. Riordan J. R., Rommens J. M., Kerem B., Alon N., Rozmahel R., Grzelczak Z., Zielenski J., Lok S., Plavsic N., Chou J. L. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science. 1989 Sep 8;245(4922):1066–1073. doi: 10.1126/science.2475911. [DOI] [PubMed] [Google Scholar]
  33. Rommens J. M., Iannuzzi M. C., Kerem B., Drumm M. L., Melmer G., Dean M., Rozmahel R., Cole J. L., Kennedy D., Hidaka N. Identification of the cystic fibrosis gene: chromosome walking and jumping. Science. 1989 Sep 8;245(4922):1059–1065. doi: 10.1126/science.2772657. [DOI] [PubMed] [Google Scholar]
  34. Sarrouilhe D., Lalégerie P., Baudry M. Endogenous phosphorylation and dephosphorylation of rat liver plasma membrane proteins, suggesting a 18 kDa phosphoprotein as a potential substrate for alkaline phosphatase. Biochim Biophys Acta. 1992 Jan 9;1118(2):116–122. doi: 10.1016/0167-4838(92)90137-3. [DOI] [PubMed] [Google Scholar]
  35. Seargeant L. E., Stinson R. A. Inhibition of human alkaline phosphatases by vanadate. Biochem J. 1979 Jul 1;181(1):247–250. doi: 10.1042/bj1810247. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Sheppard D. N., Rich D. P., Ostedgaard L. S., Gregory R. J., Smith A. E., Welsh M. J. Mutations in CFTR associated with mild-disease-form Cl- channels with altered pore properties. Nature. 1993 Mar 11;362(6416):160–164. doi: 10.1038/362160a0. [DOI] [PubMed] [Google Scholar]
  37. Swarup G., Cohen S., Garbers D. L. Inhibition of membrane phosphotyrosyl-protein phosphatase activity by vanadate. Biochem Biophys Res Commun. 1982 Aug;107(3):1104–1109. doi: 10.1016/0006-291x(82)90635-0. [DOI] [PubMed] [Google Scholar]
  38. Tabcharani J. A., Chang X. B., Riordan J. R., Hanrahan J. W. Phosphorylation-regulated Cl- channel in CHO cells stably expressing the cystic fibrosis gene. Nature. 1991 Aug 15;352(6336):628–631. doi: 10.1038/352628a0. [DOI] [PubMed] [Google Scholar]
  39. Tabcharani J. A., Low W., Elie D., Hanrahan J. W. Low-conductance chloride channel activated by cAMP in the epithelial cell line T84. FEBS Lett. 1990 Sep 17;270(1-2):157–164. doi: 10.1016/0014-5793(90)81257-o. [DOI] [PubMed] [Google Scholar]
  40. Tsui L. C. The spectrum of cystic fibrosis mutations. Trends Genet. 1992 Nov;8(11):392–398. doi: 10.1016/0168-9525(92)90301-j. [DOI] [PubMed] [Google Scholar]
  41. Van Belle H., De Broe M. E., Wieme R. J. L-p-Bromotetramisole, a new reagent for use in measuring placental or intestinal isoenzymes of alkaline phosphatase in human serum. Clin Chem. 1977 Mar;23(3):454–459. [PubMed] [Google Scholar]
  42. Van Eygen M., Dils F., Gillerot J., Verschueren E. A double-blind pediatric evaluation of levamisole in the prevention of recurrent upper respiratory tract infections. Eur J Pediatr. 1979 Jun 28;131(3):147–153. doi: 10.1007/BF00538939. [DOI] [PubMed] [Google Scholar]
  43. Van Eygen M., Znamensky P. Y., Heck E., Raymaekers I. Levamisole in prevention of recurrent upper-respiratory-tract infections in children. Lancet. 1976 Feb 21;1(7956):382–385. doi: 10.1016/s0140-6736(76)90214-2. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES